Science Explorer Back to mapMap
Discussion
Researcher · National Marrow Donor Program · United States

Stephanie Bo‐Subait

Stephanie Bo‐Subait publishes mostly in Hematology, Transplantation and Public Health, Environmental and Occupational Health, on topics such as Hematopoietic Stem Cell Transplantation, Renal Transplantation Outcomes and Treatments and Childhood Cancer Survivors' Quality of Life.

OpenAlex
World rank
#1,386,631
of 7,710,434 ranked researchers
Rank in United States
#438,337
of 1,627,098
Works
42
Citations
360
Citations per work
8.6
h-index
10
i10-index 12Top 60% in Hematology
Stephanie Bo‐Subait

What does Stephanie Bo‐Subait research?

Stephanie Bo‐Subait's work is mostly in Medicine (80%).

Health Sciences: 33 works · 79.5% of their workMedicine: 33 works · 79.5% of their workHematology: 15 works · 35.4% of their workTransplantation: 5 works · 11.0% of their workPublic Health, Environmental and Occupational Health: 4 works · 10.2% of their workPediatrics, Perinatology and Child Health: 4 works · 8.7% of their workOncology: 3 works · 7.9% of their workGenetics: 3 works · 6.3% of their workEverything else: 9 works · 20.5% of their workTHEIR WORKStephanieBo‐Subait42works
Health Sciences80%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3379.5%
  2. Everything else920.5%
  1. 1Hematology35% of their works
  2. 2Transplantation11% of their works
  3. 3Public Health, Environmental and Occupational Health10% of their works
  4. 4Pediatrics, Perinatology and Child Health9% of their works
  5. 5Oncology8% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Stephanie Bo‐Subait's research?

The keywords of their largest research topics: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Bone Marrow Niche, Graft-versus-Host Disease, Prognostic Factors, Kidney Transplantation, Renal Allograft and Childhood Cancer Survivor Study.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Hematopoietic Stem Cells412 topics
  2. Mesenchymal Stem Cells372 topics
  3. Bone Marrow Niche331 topic
  4. Graft-versus-Host Disease331 topic
  5. Prognostic Factors172 topics
  6. Kidney Transplantation131 topic
  7. Renal Allograft131 topic
  8. Childhood Cancer Survivor Study101 topic
  9. Pediatric Quality of Life Inventory101 topic
  10. Acute Lymphoblastic Leukemia91 topic
  11. Childhood Cancer91 topic
  12. AML81 topic
  13. Acute Myeloid Leukemia81 topic
  14. Antimicrobial Agents61 topic
  15. Febrile Neutropenia61 topic
  16. Cancer Genomics41 topic
  17. Multipotent41 topic
  18. Mutational Signatures41 topic
  19. Regeneration41 topic

Where does Stephanie Bo‐Subait work?

Stephanie Bo‐Subait's main affiliation in the publication record is National Marrow Donor Program, United States.

How many publications and citations does Stephanie Bo‐Subait have?

OpenAlex counts 42 works and 360 citations for Stephanie Bo‐Subait, an h-index of 10, ranking #1,386,631 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephanie Bo‐Subait. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.